Emulate is a biotechnology company developing advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
03/08/2024 | Series F-3 | $2.32MM | $xx.xx | $141.22MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
22,162,206
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/08/2024 | Series F-2 | $48.69MM | $xx.xx | $141.22MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
417,867,342
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
03/08/2024 | Series F-1 | $47.13MM | $xx.xx | $141.22MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
404,491,868
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Undisclosed Investors
|
||||||
09/07/2021 | Series E-1 | $60.38MM | $xx.xx | $409.37MM | Northpond Ventures, Perceptive Advisors | |
Price per Share
$xx.xx
Shares Outstanding
17,071,254
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
4.1x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Northpond Ventures, Perceptive Advisors
|
||||||
09/07/2021 | Series E-2 | $20.68MM | $xx.xx | $409.37MM | Northpond Ventures, Perceptive Advisors | |
Price per Share
$xx.xx
Shares Outstanding
7,309,017
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
4.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Northpond Ventures, Perceptive Advisors
|
||||||
08/16/2019 | Series D | $28.24MM | $xx.xx | $268.09MM | Alumni Ventures Group, Founders Fund, Northpond Ventures | |
Price per Share
$xx.xx
Shares Outstanding
8,588,758
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
4.1x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Alumni Ventures Group, Founders Fund, Northpond Ventures
|
||||||
06/19/2018 | Series C | $36MM | $xx.xx | $185MM | Als Investment Fund, Founders Fund, Scifi Vc | |
Price per Share
$xx.xx
Shares Outstanding
14,399,999
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
4.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Als Investment Fund, Founders Fund, Scifi Vc
|
||||||
10/20/2016 | Series B | $45MM | $xx.xx | $138.89MM | Als Investment Fund, Atel Ventures, Cedars-Sinai Medical Center, Hansj�Rg Wyss, Laboratory Corporation Of America Holdings, Nanodimension, Os Fund | |
Price per Share
$xx.xx
Shares Outstanding
18,000,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
4.0x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Als Investment Fund, Atel Ventures, Cedars-Sinai Medical Center, Hansj�Rg Wyss, Laboratory Corporation Of America Holdings, Nanodimension, Os Fund
|
||||||
07/22/2014 | Series A | $12MM | $xx.xx | $40MM | Cedars Sinai Medical Center, Nanodimension | |
Price per Share
$xx.xx
Shares Outstanding
12,000,000
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
3.3x
Dividend Rate
6.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cedars Sinai Medical Center, Nanodimension
|